Quarterly ResultMay 12, 2026, 04:13 PM
Anteris Q1 Loss $(23.0)M; Cash $283.2M after $320M Equity Raise
AI Summary
Anteris Technologies Global Corp. reported a net loss of $(23.0) million for Q1 2026, an increase from $(21.9) million in Q1 2025, primarily due to higher R&D and SG&A expenses. Net sales decreased slightly to $0.49 million. The company significantly bolstered its financial position through a public offering and a private placement with Medtronic, raising approximately $320.0 million in gross proceeds, leading to a cash balance of $283.2 million as of March 31, 2026.
Key Highlights
- Net loss for Q1 2026 was $(23.0) million, compared to $(21.9) million in Q1 2025.
- Basic and diluted loss per share improved to $(0.28) in Q1 2026 from $(0.61) in Q1 2025.
- Net sales for Q1 2026 decreased to $0.49 million from $0.56 million in Q1 2025.
- Research and development expenses increased to $(17.5) million from $(16.5) million year-over-year.
- Cash, cash equivalents, and restricted cash surged to $283.2 million as of March 31, 2026.
- The company raised approximately $320.0 million in gross proceeds from equity offerings.
- Total stockholders' equity improved to $278.4 million from a deficit of $(0.09) million.
- Net cash used in operating activities increased to $(28.7) million from $(21.5) million.